about
Radial access during percutaneous interventions in patients with acute coronary syndromes: should we routinely monitor radial artery patency by ultrasonography promptly after the procedure and in long-term observation?Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide.Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study.Influence of atorvastatin on blood pressure control in treated hypertensive, normolipemic patients - An open, pilot study.[Clinical utility of computed tomography in diagnosing sinus venosus atrial septal defect].Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction.Diagnostic biomarkers of essential arterial hypertension: the value of prostacyclin, nitric oxide, oxidized-LDL, and peroxide measurements.[Acute pulmonary trunk dissection in patients with chronic thrombo-embolic pulmonary hypertension].The significance of diminished sTWEAK and P-selectin content in platelets of patients with pulmonary arterial hypertension.Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension.The benefits of repeated measurements of B-type natriuretic peptide in patients with first ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.Myocardial perfusion and intima-media thickness in patients with subclinical hypothyroidism.sVCAM-1 concentration and carotid IMT values in patients with acute myocardial infarction--Atherosclerotic markers of the presence, progress and prognosis.The strengths and weaknesses of non-invasive parameters obtained by echocardiography and cardiopulmonary exercise testing in comparison with the hemodynamic assessment by the right heart catheterization in patients with pulmonary hypertension.Non-ischemic heart preconditioningSerum levels of CD163 and TWEAK in patients with pulmonary arterial hypertensionThe value of apelin-36 and brain natriuretic peptide measurements in patients with first ST-elevation myocardial infarctionMyocardial Infarction Changes Sphingolipid Metabolism in the Uninfarcted Ventricular Wall of the RatEffect of acute exercise and training on metabolism of ceramide in the heart muscle of the ratEffect of atherosclerosis on the mrna and protein expression of the main components of the lipolytic system in human myocardiumAdiponectin--an independent marker of coronary artery disease occurrence rather than a degree of its advancement in comparison to the IMT values in peripheral arteriesDecreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failureThe importance of intima-media thickness (IMT) measurements in monitoring of atherosclerosis progress after myocardial infarctionIatrogenic femoral pseudoaneurysms - a simple solution of inconvenient problem?Right-sided atrial tumour in a patient with abdominal neoplasmEnhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damageMMP-9 in atrial remodeling in patients with atrial fibrillationSerum adiponectin and markers of endothelial dysfunction in stable angina pectoris patients undergoing coronary artery bypass grafting (CABG)Increased platelet content of SDF-1alpha is associated with worse prognosis in patients with pulmonary prterial hypertension
P50
Q34978606-CFCA2267-2AAA-4787-A67D-D68378807C20Q37463334-8456F011-0A78-4675-B522-9CB01DFA10D1Q40939847-8AE01744-F596-4F64-BD4A-620597AF786FQ43195720-F650EA36-8E0A-45B6-9779-D849CBC73030Q43681927-CFCA15CD-B85B-4CF5-87BA-80A7ECBB9015Q44999460-00ACB003-B330-49FA-B96C-346C28856D49Q45977675-2533CD27-3F8D-4377-8989-9F1E04338166Q46463708-FC8ABA45-1E44-4EE8-AC62-96D0C0160107Q47333025-66F395E0-1C59-4259-B529-15CBF122E16AQ48178040-21DA27A0-468F-44C3-8489-C60B278BCDB3Q48261958-27EC778B-4704-4DA2-B2AE-16C42778C2FCQ48290883-5447D4D6-68F5-41E8-8D17-F39134876418Q51021848-6A7BD59A-E6D8-4770-B720-113AD90B2C52Q53630178-268106CB-61AA-424A-8407-5E45CBCE80FBQ53751146-953F0249-A5A8-43B4-8F93-641F98078A88Q57179238-972A67EC-556F-4CB0-82FF-9A5C04B987E2Q57212429-D3A5A3AB-BE64-4225-84D3-8CA254FF90EEQ59843797-D572B599-9EBF-44EE-AB0F-A6C8DF01835DQ62034098-2636E8E7-BF7C-4189-A756-E78B371471C0Q62887355-83A74673-F010-469B-A644-400ABC8518D0Q63805077-484BF2A0-85DE-47CA-9B1E-EC31B5F7DB4FQ83305634-F9C3EF8D-73B6-4571-BD63-252931A1E1F5Q83379430-3ECB2C9F-C012-4214-A96A-71103D88C1D1Q84048552-127B8D3B-AB6B-4A9A-AA0D-4E3705EAE2E0Q85065172-A083E2C0-DC56-4146-BFD8-3553AEED8627Q85329174-892497B7-811B-4643-AD79-C2305D2A206BQ85573893-BE6B7193-AC6E-4410-ABB4-3B80E421E084Q87107155-804B6505-F2DE-41AF-A2FA-A5552B03D7A2Q87535075-A154D381-B53E-441C-BAE4-EB12E0AA216AQ88263425-96190CCD-9A7B-4184-A4E3-893C00AF3C28
P50
description
researcher ORCID ID = 0000-0001-9214-4535
@en
wetenschapper
@nl
name
Malgorzata Knapp
@ast
Malgorzata Knapp
@en
Malgorzata Knapp
@es
Malgorzata Knapp
@nl
Małgorzata Knapp
@pl
type
label
Malgorzata Knapp
@ast
Malgorzata Knapp
@en
Malgorzata Knapp
@es
Malgorzata Knapp
@nl
Małgorzata Knapp
@pl
altLabel
Małgorzata Anna Knapp
@pl
Małgorzata Knapp
@en
prefLabel
Malgorzata Knapp
@ast
Malgorzata Knapp
@en
Malgorzata Knapp
@es
Malgorzata Knapp
@nl
Małgorzata Knapp
@pl
P106
P1153
7202388648
P21
P31
P3124
P496
0000-0001-9214-4535